Abvc Biopharma (ABVC) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Abvc Biopharma (ABVC) over the last 14 years, with Q3 2025 value amounting to -$73.3 million.
- Abvc Biopharma's Retained Earnings fell 388.81% to -$73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$73.3 million, marking a year-over-year decrease of 388.81%. This contributed to the annual value of -$68.9 million for FY2024, which is 765.51% down from last year.
- Per Abvc Biopharma's latest filing, its Retained Earnings stood at -$73.3 million for Q3 2025, which was down 388.81% from -$72.0 million recorded in Q2 2025.
- In the past 5 years, Abvc Biopharma's Retained Earnings registered a high of -$26.8 million during Q1 2021, and its lowest value of -$73.3 million during Q3 2025.
- In the last 5 years, Abvc Biopharma's Retained Earnings had a median value of -$59.0 million in 2023 and averaged -$55.6 million.
- Per our database at Business Quant, Abvc Biopharma's Retained Earnings tumbled by 6613.81% in 2022 and then crashed by 63.27% in 2025.
- Abvc Biopharma's Retained Earnings (Quarter) stood at -$38.5 million in 2021, then plummeted by 42.68% to -$54.9 million in 2022, then decreased by 16.65% to -$64.0 million in 2023, then fell by 7.66% to -$68.9 million in 2024, then dropped by 6.3% to -$73.3 million in 2025.
- Its Retained Earnings stands at -$73.3 million for Q3 2025, versus -$72.0 million for Q2 2025 and -$69.8 million for Q1 2025.